Prot #002-00: Randomized, Phase II Study of MK-3475 versus Chemotherapy in Patients with Advanced Melanoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/14/134/14/19

Funding

  • Merck Sharp & Dohme Research Laboratories (Prot #002-00)